Richard J. Lozano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard J. Lozano has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alex B. Green
Yale School of Medicine 1 Department of Laboratory Medicine New Haven, CT, USA
1 shared publication Byung-Chul Lee
1 shared publication- Carys L. Kenny-Howell
Yale School of Medicine
1 shared publication - Cynthia E. Dunbar
Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Ellen F. Foxman
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06520, USA; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06520, USA
1 shared publication - Gregory Germain
Yale School of Medicine 3 Department of Pediatrics New Haven, CT, USA
1 shared publication
Latest Publications
- Open Access
- 16 January 2026
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (5) , 541-556
A systematic approach to detection of epileptogenic foci on imaging: protocols, entities, search pattern, and reporting tools
Accurate detection of epileptogenic lesions on imaging requires a systematic search for abnormalities with diverse etiologies, appearances, and locations. This article provides a practical approach to the detection of epileptogenic foci for radiologists. First, we review protocols tailored to seizure evaluation. Next, we present a pictorial review of structural etiologies for seizure, including temporal lobe pathologies, developmental malformations, neoplastic lesions, vascular lesions, and infectious/inflammatory processes. We provide a step-by-step, systematic approach to ensure detection of the manifold potential pathologies visible on imaging as well as appropriate correlation with clinical findings. Finally, we present example reporting templates which can ensure efficient reporting by radiologists as well as serve as mnemonic aids.
- 16 January 2026
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (5) , 541-556
Open AccessA systematic approach to detection of epileptogenic foci on imaging: protocols, entities, search pattern, and reporting tools
Accurate detection of epileptogenic lesions on imaging requires a systematic search for abnormalities with diverse etiologies, appearances, and locations. This article provides a practical approach to the detection of epileptogenic foci for radiologists. First, we review protocols tailored to seizure evaluation. Next, we present a pictorial review of structural etiologies for seizure, including temporal lobe pathologies, developmental malformations, neoplastic lesions, vascular lesions, and infectious/inflammatory processes. We provide a step-by-step, systematic approach to ensure detection of the manifold potential pathologies visible on imaging as well as appropriate correlation with clinical findings. Finally, we present example reporting templates which can ensure efficient reporting by radiologists as well as serve as mnemonic aids.
- Open Access
- 1 July 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (9)
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children
Studies during the COVID-19 pandemic showed that children had heightened nasal innate immune responses compared with adults. To evaluate the role of nasal viruses and bacteria in driving these responses, we performed cytokine profiling and comprehensive, symptom-agnostic testing for respiratory viruses and bacterial pathobionts in nasopharyngeal samples from children tested for SARS-CoV-2 in 2021–22 (n = 467). Respiratory viruses and/or pathobionts were highly prevalent (82% of symptomatic and 30% asymptomatic children; 90 and 49% for children <5 years). Virus detection and load correlated with the nasal interferon response biomarker CXCL10, and the previously reported discrepancy between SARS-CoV-2 viral load and nasal interferon response was explained by viral coinfections. Bacterial pathobionts correlated with a distinct proinflammatory response with elevated IL-1β and TNF but not CXCL10. Furthermore, paired samples from healthy 1-year-olds collected 1–2 wk apart revealed frequent respiratory virus acquisition or clearance, with mucosal immunophenotype changing in parallel. These findings reveal that frequent, dynamic host–pathogen interactions drive nasal innate immune activation in children.
- 1 July 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (9)
Open AccessHigh burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children
Studies during the COVID-19 pandemic showed that children had heightened nasal innate immune responses compared with adults. To evaluate the role of nasal viruses and bacteria in driving these responses, we performed cytokine profiling and comprehensive, symptom-agnostic testing for respiratory viruses and bacterial pathobionts in nasopharyngeal samples from children tested for SARS-CoV-2 in 2021–22 (n = 467). Respiratory viruses and/or pathobionts were highly prevalent (82% of symptomatic and 30% asymptomatic children; 90 and 49% for children <5 years). Virus detection and load correlated with the nasal interferon response biomarker CXCL10, and the previously reported discrepancy between SARS-CoV-2 viral load and nasal interferon response was explained by viral coinfections. Bacterial pathobionts correlated with a distinct proinflammatory response with elevated IL-1β and TNF but not CXCL10. Furthermore, paired samples from healthy 1-year-olds collected 1–2 wk apart revealed frequent respiratory virus acquisition or clearance, with mucosal immunophenotype changing in parallel. These findings reveal that frequent, dynamic host–pathogen interactions drive nasal innate immune activation in children.
- Open Access
- 1 November 2021
- Published by Elsevier in Molecular Therapy
- Vol. 29 (11) , 3205-3218
Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells
- 1 November 2021
- Published by Elsevier in Molecular Therapy
- Vol. 29 (11) , 3205-3218
Open AccessUnderstanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells